tiprankstipranks
Ensysce Biosciences (ENSC)
NASDAQ:ENSC
US Market
Holding ENSC?
Track your performance easily

Ensysce Biosciences (ENSC) Income Statement

241 Followers

Ensysce Biosciences Income Statement

Last quarter (Q3 2024), Ensysce Biosciences's total revenue was $3.42M, an increase of Infinity% from the same quarter last year. In Q3, Ensysce Biosciences's net income was $661.77K. See Ensysce Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21
Total Revenue
$ 5.35M$ 2.23M$ 2.52M$ 3.53M
Cost of Revenue
----
Gross Profit
$ 4.42M$ 2.23M$ 2.52M$ 3.53M
Operating Expense
$ 6.43M$ 10.72M$ 24.22M$ 23.40M
Operating Income
$ -6.31M$ -10.72M$ -24.22M$ -19.87M
Net Non Operating Interest Income Expense
$ -1.59M$ -353.94K$ 1.25M$ -1.30M
Other Income Expense
$ -349.22K$ 445.86K$ 1.26M$ 8.78M
Pretax Income
$ -3.26M$ -10.63M$ -24.21M$ -29.95M
Tax Provision
$ -77.24K$ -77.24K$ -175.16K$ -139.21K
Earnings From Equity Interest Net Of Tax
----
Net Income Common Stockholders
$ -7.93M$ -10.63M$ -25.09M$ -29.89M
Basic EPS
$ -1.46$ -4.69$ -139.44$ -355.20
Diluted EPS
$ -1.46$ -4.69$ -139.44$ -355.20
Basic Average Shares
$ 27.04M$ 2.26M$ 179.93K$ 84.02K
Diluted Average Shares
$ 27.04M$ 2.26M$ 179.93K$ 84.02K
Dividend Per Share
----
Total Operating Income As Reported
----
Reported Normalized Basic E P S
----
Reported Normalized Diluted E P S
----
Rent Expense Supplemental
----
Total Expenses
$ 6.43M$ 10.72M$ 24.22M$ 23.40M
Net Income From Continuing And Discontinued Operation
$ -7.91M$ -10.61M$ -24.17M$ -29.08M
Normalized Income
$ -4.86M$ -10.72M-$ -29.29M
Interest Expense
----
EBIT
$ -2.05M$ -10.27M$ -24.10M$ -28.65M
EBITDA
$ -848.32K$ -10.27M$ -24.10M$ -28.65M
Currency in USD

Ensysce Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis